Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2004-4-15
pubmed:abstractText
Hypoxia-inducible factor 1 alpha (hif-1alpha) furnishes tumor cells with the means of adapting to stress parameters like tumor hypoxia and promotes critical steps in tumor progression and aggressiveness. We investigated the role of hif-1alpha expression in patients with node-positive breast cancer.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-10582706, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-10866281, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-10928066, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-10987269, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-11181778, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-11280732, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-11306467, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-11410504, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-11443623, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-11556841, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-11606368, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-11804750, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-11980639, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-12060624, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-12095550, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-12128120, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-12209691, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-12213597, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-12605983, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-12627523, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-12738326, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-1419637, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-2040005, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-2334928, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-8079743, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-8278585, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-8538748, http://linkedlifedata.com/resource/pubmed/commentcorrection/15084243-8971187
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/HIF1A protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Hypoxia-Inducible Factor 1, alpha..., http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
pubmed:status
MEDLINE
pubmed:issn
1465-542X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
R191-8
pubmed:dateRevised
2010-9-20
pubmed:meshHeading
pubmed-meshheading:15084243-Humans, pubmed-meshheading:15084243-Breast Neoplasms, pubmed-meshheading:15084243-Aged, pubmed-meshheading:15084243-Aged, 80 and over, pubmed-meshheading:15084243-Prognosis, pubmed-meshheading:15084243-Female, pubmed-meshheading:15084243-Adult, pubmed-meshheading:15084243-Prednisone, pubmed-meshheading:15084243-Middle Aged, pubmed-meshheading:15084243-Life Tables, pubmed-meshheading:15084243-Methotrexate, pubmed-meshheading:15084243-Lymphatic Metastasis, pubmed-meshheading:15084243-Cyclophosphamide, pubmed-meshheading:15084243-Fluorouracil, pubmed-meshheading:15084243-Neoplasm Proteins, pubmed-meshheading:15084243-Vincristine, pubmed-meshheading:15084243-Combined Modality Therapy, pubmed-meshheading:15084243-Antineoplastic Agents, Hormonal, pubmed-meshheading:15084243-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15084243-Risk, pubmed-meshheading:15084243-Neoplasm Staging, pubmed-meshheading:15084243-Cohort Studies, pubmed-meshheading:15084243-Survival Analysis, pubmed-meshheading:15084243-Doxorubicin
More...